Amlodipine Valsartan Biovis 5 mg/160 mg

Amlodipine Valsartan Biovis 5 mg/160 mg is a medicine authorised by Swissmedic under authorisation number 70584. The authorisation holder is Biovis Life Sciences AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 December 2025 and the authorisation is valid without a time limit. ATC code C09DB01 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 70584
  • ATC C09DB01
  • Synthetic medicines
Authorisation data
Authorisation number70584
NameAmlodipine Valsartan Biovis 5 mg/160 mg
Full nameAmlodipine Valsartan Biovis 5 mg/160 mg, compresse rivestite con film
Authorisation holderBiovis Life Sciences AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DB01
First authorisation11 December 2025
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Amlodipine Valsartan Biovis 5 mg/160 mg, compresse rivestite con filmB11 December 2025
2Amlodipine Valsartan Biovis 10 mg/160 mg, compresse rivestite con filmB11 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)C09DB0102.07.2.B
228Tablette(n)C09DB0102.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Amlodipine Valsartan Biovis 5 mg/160 mg authorised in Switzerland?

Yes. Amlodipine Valsartan Biovis 5 mg/160 mg is authorised by Swissmedic under authorisation number 70584, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Amlodipine Valsartan Biovis 5 mg/160 mg have?

Amlodipine Valsartan Biovis 5 mg/160 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Amlodipine Valsartan Biovis 5 mg/160 mg?

The authorisation holder is Biovis Life Sciences AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com